Congress Asset Management Co
Source: SEC Form 13F · as of Mar 2026Congress Asset Management Co holds 9 biotech & pharma companies tracked by BioSniper, totaling $332.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
9
Total value held
$332.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Ligand Pharmaceuticals Incorporated (LGND)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| LGNDLigand Pharmaceuticals Incorporated | 504,637 | $100.8M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 285,739 | $94.5M |
| TGTXTG THERAPEUTICS, INC. | 2,168,081 | $72.0M |
| VCELVericel Corp | 1,506,918 | $48.5M |
| TNGXTango Therapeutics, Inc. | 341,361 | $7.1M |
| ACADACADIA PHARMACEUTICALS INC | 160,794 | $3.6M |
| MLTXMoonLake Immunotherapeutics | 178,555 | $3.3M |
| CCCCC4 Therapeutics, Inc. | 830,624 | $2.2M |
| IONSIONIS PHARMACEUTICALS INC | 3,946 | $296K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.